AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Amazon Up, Walgreens, Nike & McPlant Down
Motley Fool Money
Impact of Weight Loss Drug on Med Tech Industry and ResMed's Business
2min Snip
00:00
Summary
Transcript
Episode notes
The chapter explores how weight loss drugs like ZEPBOUND can potentially disrupt companies like ResMed, known for producing CPAP machines for sleep apnea, despite their growing sales. The discussion also raises concerns about the long-term effects of GLP-1 drugs, causing investor uncertainty.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode